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Human H7N9 virus induces a more
pronounced pro-inflammatory cytokine but
an attenuated interferon response in
human bronchial epithelial cells when
compared with an epidemiologically-linked
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Abstract
Background: Avian influenza virus H7N9 has jumped species barrier, causing sporadic human infections since 2013.
We have previously isolated an H7N9 virus from a patient, and an H7N9 virus from a chicken in a live poultry
market where the patient visited during the incubation period. These two viruses were genetically highly similar.
This study sought to use a human bronchial epithelial cell line model to infer the virulence of these H7N9 viruses in
humans.
Methods: Human bronchial epithelial cell line Calu-3 was infected with two H7N9 viruses (human H7N9-HU and
chicken H7N9-CK), a human H5N1 virus and a human 2009 pandemic H1N1 virus. The infected cell lysate was
collected at different time points post-infection for the determination of the levels of pro-inflammatory cytokines
(tumor necrosis factor α [TNF-α] and interleukin 6 [IL-6]), anti-inflammatory cytokines (interleukin 10 [IL-10] and
transforming growth factor beta [TGF-β]), chemokines (interleukin 8 [IL-8] and monocyte chemoattractant protein 1
[MCP-1]), and interferons (interferon β [IFN-β] and interferon lambda 1 [IFNL1]). The viral load in the cell lysate was
also measured.
Results: Comparison of the human and chicken H7N9 viruses showed that H7N9-HU induced significantly higher
levels of TNF-α at 12 h post-infection, and significantly higher levels of IL-8 from 12 to 48 h post-infection than
those of H7N9-CK. However, the level of IFNL1 was lower for H7N9-HU than that of H7N9-CK at 48 h post-infection
(P < 0.001). H7N9-HU had significantly higher viral loads than H7N9-CK at 3 and 6 h post-infection. H5N1 induced
significantly higher levels of TNF-α, IL-6, IL-8, IL-10 and MCP-1 than those of H7N9 viruses at 48 h post-infection.
Conversely, H1N1 induced lower levels of TNF-α, IL-10, MCP-1, IFNL1 and IFN-β when compared with H7N9 viruses
at the same time point.
(Continued on next page)
* Correspondence: kyyuen@hku.hk
†Equal contributors
1Department of Microbiology, The University of Hong Kong, Hong Kong
Special Administrative Region, China
2State Key Laboratory for Emerging Infectious Diseases, The University of
Hong Kong, Hong Kong Special Administrative Region, China
Full list of author information is available at the end of the article
© 2016 To et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
To et al. Virology Journal  (2016) 13:42 
DOI 10.1186/s12985-016-0498-2
(Continued from previous page)
Conclusions: H7N9-HU induced higher levels of pro-inflammatory IL-6 and IL-8 and exhibited a more rapid viral
replication than H7N9-CK. However, the level of antiviral IFNL1 was lower for H7N9-HU than H7N9-CK. Our results
suggest that the gained properties in modulating human innate immunity by H7N9-HU transformed it to be a
more virulent virus in humans than H7N9-CK.
Keywords: Avian influenza virus, H7N9, Human, Chicken, Cytokine, Chemokine, Interferon, Viral load, Interferon
lambda 1, IL-8
Background
The avian influenza H7N9 virus has crossed species bar-
rier, with the first cluster of human infections identified
in early 2013 [1–3]. Subsequently, it has spread rapidly
across the mainland China, and travel-related cases were
identified in Hong Kong, Taiwan, Malaysia and Canada
[4–7]. H7N9 virus is the most rapidly spreading zoonotic
influenza virus affecting humans, with at least 680 cases
in less than 3 years since first identified in humans [8].
H7N9 infection is a highly fatal disease in humans.
The case-fatality rate of H7N9 infection in humans is
about 40 % [9], which is much higher than that of the
2009 pandemic H1N1 infection [10], but lower than that
for H5N1 infection [11]. Unlike most patients with
seasonal or pandemic influenza virus infection which
present with self-limiting acute upper respiratory ill-
ness, the majority of patients with laboratory-confirmed
H7N9 infections present with rapidly progressive
community-acquired pneumonia, leukopenia, lympho-
penia, thrombocytopenia, impaired coagulation profile,
deranged liver and renal function, and some patients
succumbed with adult respiratory distress syndrome
and multiorgan dysfunction [12–15]. These differences
in clinical severity and pathology among H7N9, H5N1
and H1N1 may be related to the differential ability of
the viruses to induce cytokine and chemokine response.
Cytokine and chemokine dysregulation is a hallmark in
patients suffering from severe influenza [16–18]. Pa-
tients with H7N9 virus infection also had poorer anti-
body response when compared with those of H5N1 and
H1N1 viruses [19]. The suboptimal humoral response
induced by H7N9 virus may be related to their internal
genes [20].
Epidemiological and phylogenetic analysis suggested that
H7N9 virus is primarily transmitted from poultries to
humans in live poultry markets (LPM) [2, 21–23]. In our
previous study, we have isolated an H7N9 virus from a pa-
tient (A/Zhejiang/DTID-ZJU01/2013[H7N9]) (H7N9-HU)
and an H7N9 virus from a chicken in an epidemiologically-
linked LPM (A/chicken/Zhejiang/DTID-ZJU01/2013[H7
N9]) (H7N9-CK) [2]. H7N9-HU and H7N9-CK had high
nucleotide similarity. In a subsequent study, we have shown
that H7N9-CK could cause lethal infection in mice without
prior adaptation, and was associated with high pulmonary
levels of pro-inflammatory cytokines [24]. In this study, we
used a human bronchial epithelial cell line model to infer
the virulence of the human and chicken H7N9 viruses in
humans.
Methods
Cell and virus isolates
H7N9-HU was isolated from a 64-year-old male patient
from Zhejiang who bought live poultry from a LPM within
the incubation period, and H7N9-CK was isolated from a
chicken from the LPM where that patient bought the live
poultry [2]. A/Hong Kong/415742/2009(H1N1) (H1N1)
and A/Vietnam/1194/2004(H5N1) (H5N1) were isolated
from infected patients [25, 26]. The viruses were propa-
gated in 10-day-old specific-pathogen-free (SPF) chicken
embryos at 37 °C for 48 h as we described previously [27].
Aliquots of virus stock were stored at −80 °C until use.
Calu-3 cell line (ATCC no. HTB-55) was used for the infec-
tion experiments. All experimental protocols followed the
standard operating procedures of the approved biosafety
level 3 facility as we previously described [25, 26, 28].
Viral inoculation into Calu-3 cells
Calu-3 cells were seeded onto 96-well tissue culture
plates, at 2.5 × 104 cells per well with Dulbecco’s Modi-
fied Eagle Medium (DMEM) supplemented with 20 %
fetal calf serum (FCS), 100 IU/ml of penicillin, and
100 μg/ml of streptomycin. The culture plates were in-
cubated at 37 °C and 5 % CO2 for 48 h prior to the ex-
periment. Cells were inoculated with 3 multiplicity of
infection (M.O.I.) of each virus. After 1 h of viral ad-
sorption, the medium was removed and cells were
washed twice with medium before further incubation for
3, 6, 12, 24 and 48 h in DMEM containing tosylsulfonyl
phenylalanylchloromethyl ketone (TPCK)-treated trypsin
(0.5 μg/ml) (Sigma). Cell lysates were collected for cyto-
kine and viral load assays. The experiments were per-
formed in triplicate.
Determination of the levels of cytokines and chemokines
The levels of cytokines and chemokines were deter-
mined by real-time reverse transcription-quantitative
polymerase chain reaction (RT-qPCR) as we described
previously [25]. RNA extraction was performed using
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RNeasy Mini Spin Column (QIAgen). The RNA was
eluted in 50 μl of RNase-free water and was used as the
template for RT-qPCR. Reverse transcription was per-
formed using the oligo(dt) primer with the SuperScript III
kit (Invitrogen). RT-qPCR assays for tumor necrosis factor
α (TNF-α), interleukin 6 (IL-6), interleukin 8 (IL-8), inter-
leukin 10 (IL-10), transforming growth factor beta (TGF-β),
interferon lambda 1 (IFNL1), interferon β (IFN-β), and
monocyte chemoattractant protein 1 (MCP-1) were per-
formed as described previously with primers and conditions
listed in Table 1, using glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) for normalization [25]. cDNA was
amplified in a LightCycler 2.0 (Roche) with 20 μl reaction
mixtures containing FastStart DNA Master SYBR Green I
Mix reagent kit (Roche), 2 μl cDNA, 2 or 4 mMMgCl2 and
1 μM primers at 95 °C for 10 min followed by 50 cycles of
denaturation, annealing and extension. Melting curve ana-
lysis was performed for each primer pair at the end of the
reaction to confirm the specificity of the assay.
Viral load
To study viral replication kinetics, viral titer from cell ly-
sates collected at 3, 6, 12, 24 and 48 h post-infection were
measured by RT-qPCR as described previously [25].
Statistical analysis
Statistical analysis was performed using GraphPad Prism
6.0. The levels of cytokines and chemokines were
expressed as fold-increase from mock-infected cells. The
cytokine/chemokine levels and viral loads of different
viruses were compared using Student’s t-test when com-
paring between two viruses, and two-way ANOVA test
corrected for multiple comparisons using Tukey post-
hoc test when comparing 3 different viruses. A P value
of <0.05 was considered statistically significant.
Results
We compared the cytokine and chemokine levels be-
tween the human and chicken H7N9 viruses in a human
bronchial epithelial cell line Calu-3. At 12 h post-
infection, the mean level of TNF-α was significantly
higher for H7N9-HU (220-fold) than that of H7N9-CK
(55-fold) (P = 0.010). The mean level of TNF-α at 24 h
post-infection was also higher for H7N9-HU (458-fold)
than that of H7N9-CK (224-fold), almost reaching statis-
tical significance (P = 0.068). However, at 48 h post-
infection, the mean level of TNF-α was similar be-
tween H7N9-HU (289-fold) and H7N9-CK (307-fold)
(P = 0.802). H7N9-HU also induced significantly
higher levels of IL-8 from 12–48 h post-infection
than those of H7N9-CK. Conversely, the mean level
of IFNL1 was significantly lower for H7N9-HU (39-
fold) than that of H7N9-CK (55-fold) at 48 h post-
infection (P = 0.0005). The mean level of MCP-1 was
also significantly lower for H7N9-HU than H7N9-CK
at 48 h post-infection (P = 0.014). There was no sig-
nificant difference for other cytokines/chemokines.
Next, we compared the H7N9 viruses with the more
virulent H5N1 and the less virulent H1N1 viruses. When
compared with H7N9-CK or H7N9-HU, H5N1 induced
significantly higher levels of IL-8 at 12 h post-infection;
IL-8, IL-6, IL-10 and MCP-1 at 24 h post-infection; and
IL-8, IL-6, IL-10, MCP-1 and TNF-α at 48 h post-
infection (Fig. 1). Unlike H5N1, H1N1 induced signifi-
cantly lower levels of IL-6, MCP-1 and TNF-α at 24 h
post-infection; and MCP-1, TNF-α, IL-10, IFNL1 and
IFN-β at 48 h post-infection when compared with
H7N9-CK or H7N9-HU.
The viral kinetics were also determined (Fig. 2). At 3 and
6 h post infection, the viral load achieved by H7N9-CK
were about 1 log lower than that of H7N9-HU (P < 0.005).
At 48 h post-infection, the viral load of H7N9-CK was sig-
nificantly higher than those of H7N9-HU (P < 0.001).
Table 1 Primers and conditions for real-time RT-PCR
Cytokines Primers
Forward Backward Mg conc.
(mM)
Denaturation Annealing Extension
TNF-α GCCAGAGGGCTGATTAGAGA CAGCCTCTTCTCCTTCCTGAT 2 95 °C 10s 60 °C 5 s 72 °C 5 s
MCP-1 GCAATCAATGCCCCAGTCA TGCTGCTGGTGATTCTTCTATAGCT 2 95 °C 10s 55 °C 5 s 72 °C 5 s
IL-6 GGTACATCCTCGACGGCATCT GTGCCTCTTTGCTGCTTTCAC 2 95 °C 10s 55 °C 5 s 72 °C 5 s
IFN-β GCCGCATTGACCATCT CACAGTGACTGTACTCCT 4 95 °C 10s 55 °C 5 s 72 °C 11 s
IFNL1 GAAGCAGTTGCGATTTAGCC GAAGCTCGCTAGCTCCTGTG 2 95 °C 10s 60 °C 5 s 72 °C 7 s
IL-10 CAAATGAAGGATCAGCTGGACAA GCATCACCTCCTCCAGGTAAAAC 2 95 °C 10s 55 °C 5 s 72 °C 5 s
TGF-β CCCAGCATCTGCAAAGCTC GTCAATGTACAGCTGCCGCA 2 95 °C 10s 55 °C 5 s 72 °C 5 s
IL-8 AGCTGGCCGTGGCTCTCT CTGACATCTAAGTTCTTTAGCACTCCTT 2 95 °C 10s 55 °C 5 s 72 °C 5 s
GAPDH ATTCCACCCATGGCAAATTC CGCTCCTGGAAGATGGTGAT 2 95 °C 10s 55 °C 5 s 72 °C 5 s
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Fig. 1 The cytokine/chemokine mRNA levels in Calu-3 cell line infected with A/Zhejiang/DTID-ZJU01/2013(H7N9) (H7N9-HU), A/chicken/Zhe-
jiang/DTID-ZJU01/2013(H7N9) (H7N9-CK), A/Hong Kong/415742/2009(H1N1) (H1N1) and A/Vietnam/1194/2004(H5N1) (H5N1). The experiment
was performed in triplicate. Data were shown as mean ± standard error of mean. * indicates P < 0.05 when comparing H7N9-HU with H7N9-
CK; • indicates P < 0.05 when comparing H5N1 with H7N9-CK or H7N9-HU; # indicates P < 0.05 when comparing H1N1 with H7N9-CK
or H7N9-HU
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Discussion
Severe influenza is characterized by rapidly progressive
pneumonia, acute respiratory distress syndrome and mul-
tiorgan failure [11, 12, 14]. An exaggerated innate immune
response is observed in severe influenza cases, manifested
with elevated levels of pro-inflammatory or anti-
inflammatory cytokines and chemokines [15–17, 29, 30].
Although some studies have compared human H7N9 vi-
ruses with poultry H7N9 viruses or with other subtypes of
human or avian influenza viruses [31–35], there have not
been any studies which compared the cytokine/chemokine
responses and the replication of H7N9 viruses isolated
from human and poultry in epidemiologically-linked mar-
kets. In the current study, we compared human and
poultry H7N9 viruses that were closely related both epide-
miologically and phylogenetically. When compared with
the chicken H7N9-CK, the human H7N9-HU induced a
stronger TNF-α response at 12 and 24 h post-infection,
but a weaker IFNL1 response between 12 and 48 h post-
infection. H7N9-HU also replicated more rapidly than
H7N9-CK in the first 6 h. H7N9-HU and H7N9-CK
are highly similar, with 99.4 % and 99.7 % nucleotide
identity in their hemagglutinin and neuraminidase
genes, respectively [2]. However, there are two major
amino acid differences between the human and
chicken H7N9 virus. H7N9-HU has a Gln226Leu sub-
stitution (H3 numbering) in the hemagglutinin, which
is responsible for an increase binding affinity to the
human type α-2,6-linked sialic acid receptor. H7N9-
HU also contains an Asp701Asn substitution in PB2,
which has been shown to enhance transmission in
guinea pigs.
Our cytokine/chemokine findings suggest that H7N9-
HU induced a greater proinflammatory response than
H7N9-CK. These results corroborate with the results of
an in vivo model by Zhang et al. [35]. In their study, fer-
rets infected with human H7N9 strains had greater
weight loss, more severe bronchopneumonia, and higher
viral loads in the tonsils, trachea and lung than ferrets
infected with a chicken H7N9 strain. However, the cyto-
kine/chemokine profiles or other immune profiles of
these ferrets were not reported.
We have chosen Calu-3 cell line because bronchial
epithelial cell is one of the cell types affected in patients
with severe influenza [36]. Calu-3 has been widely used
for studies on the pathogenesis of influenza virus and
other respiratory viruses [31, 37–39]. McDermott et al.
showed that host response induced by high pathogenic
avian influenza virus in Calu-3 correlated with that of
mouse and macaque models [40].
In this study, we have shown that the level of TNF-α
was higher in Calu-3 cells infected with H7N9-HU than
that of H7N9-CK. TNF-α is a major pro-inflammatory
cytokine. Our results corroborate with those in a study
showing higher pulmonary level of TNF-α in mice in-
fected with a human H7N9 virus when compared to that
of mice infected with a duck H7N9 virus from 2009
[41]. The level of TNF-α was also increased in H7N9 pa-
tients [2], although the level of TNF-α was not associ-
ated with the prognosis of patients [17, 42].
The level of IL-8 was also higher for H7N9-HU than
that of H7N9-CK. IL-8, or CXCL8, is a chemokine which
attracts and activates neutrophils. Previous studies showed
that human H7N9 and H5N1 viruses induced higher
levels of IL-8 than seasonal H3N2 virus or an H7N9 virus
isolated from a shoveler in 2007 [31]. In patients with
2009 pandemic H1N1 virus infection, the levels of IL-8
were also found to be higher in patients with severe dis-
ease than those with mild disease [10]. In humans, IL-8
has been associated with acute lung injury [43].
On the contrary, the levels of IFNL1 and MCP-1 were
lower in Calu-3 cells infected with H7N9-HU than that
of H7N9-CK at 48 h post-infection. IFNL1, also known
as IL-29, is an antiviral type III interferon. Administra-
tion of IFNL1 can reduce the viral load in vitro [44]. In
previous studies, avian influenza viruses H5N2 and
H9N2 induced robust IFNL1 response in the lung alveo-
lar epithelial A549 cells [45]. MCP-1 is a chemokine
mainly responsible for recruiting monocytes. MCP-1
is required for protective response, as treatment of
influenza-infected mice with MCP-1 antibody resulted
in greater lung damage [46]. However, a higher level
of MCP-1 was found in patients who died than those
survivors at week 2 post-infection, suggesting that a
Fig. 2 Growth properties of influenza A virus in Calu-3 cell line. The
viruses were A/Zhejiang/DTID-ZJU01/2013(H7N9) (H7N9-HU), A/
chicken/Zhejiang/1/2013(H7N9) (H7N9-CK), A/Hong Kong/415742/
2009(H1N1) (H1N1) and A/Vietnam/1194/2004(H5N1) (H5N1). The
experiment was performed in triplicate. Data were shown as mean ±
standard error of mean. * indicates P < 0.05 when comparing H7N9-HU
with H7N9-CK
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persistently high level of MCP-1 is associated with
poorer prognosis [17].
The viral titers of H7N9-HU were higher than those of
H7N9-CK at 3 and 6 h post-infection. This is consistent
with another study which showed that the viral titers of
the human H7N9 viruses were higher than those of
phylogenetically unrelated duck H7N9 virus and the
2009 pandemic H1N1 virus in differentiated normal
human bronchial epithelial cells [47]. In another study, a
human H7N9 virus was also shown to have better
replication in explanted human lung tissue than low-
pathogenic avian H7N1 and H7N7 isolated from turkeys
[48]. The lower level of IFNL1 and a more rapid viral
replication in H7N9-HU-infected cells suggest that
H7N9-HU has acquired additional characteristics that
enhance the virulence in humans.
Similar to other studies, we have demonstrated that
the cytokine/chemokine mRNA expression levels and
the viral loads of H7N9, H5N1 and H1N1 virus in Calu-
3 cells correlated well with disease severity observed in
humans [31]. The avian influenza virus H5N1, which has
a case-fatality rate about 53 % [9], induced the highest
mRNA expression levels of most tested cytokines/che-
mokines. On the other hand, the 2009 pandemic H1N1,
which has a <1 % case-fatality rate [10], induced the
lowest mRNA levels of cytokines/chemokines and the
lowest viral load. The avian influenza virus H7N9, which
has a case-fatality rate of 40 % [9], induced moderate
levels of cytokines/chemokines. H7N9 was also shown to
induce a cytokine profile between that of H5N1 and sea-
sonal influenza viruses in primary human macrophages
and those in endothelial cells [31, 49].
Conclusions
In summary, while only few adaptive mutations were
observed between H7N9 human and avian viruses, the
results of our study suggested that H7N9-HU is more
virulent in humans than H7N9-CK. The ability to induce
inflammation and the kinetics of viral replication in
human cells may be common parameters in predicting
the virulence and replication potential of an emerging
avian influenza virus in humans.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KKWT conceived of the study, participated in its design and coordination,
analyzed and interpreted the data, drafted the manuscript, and approved the
final version of the manuscript. CCYL participated in the acquisition, analysis
and interpretation of data, revised the manuscript critically for important
intellectual content, and approved the final version of the manuscript. PCYW
conceived of the study, participated in its design, analyzed and interpreted
the data, revised the manuscript critically for important intellectual content,
and approved the final version of the manuscript. SKPL analyzed and
interpreted the data, revised the manuscript critically for important
intellectual content, and approved the final version of the manuscript. JFWC
analyzed and interpreted the data, revised the manuscript critically for
important intellectual content, and approved the final version of the
manuscript. KHC participated in the acquisition, analysis and interpretation of
data, revised the manuscript critically for important intellectual content, and
approved the final version of the manuscript. AJXZ analyzed and interpreted
the data, revised the manuscript critically for important intellectual content,
and approved the final version of the manuscript. HC analyzed and
interpreted the data, revised the manuscript critically for important
intellectual content, and approved the final version of the manuscript. KYY
conceived of the study, participated in its design and coordination, analyzed
and interpreted the data, revised the manuscript critically for important
intellectual content, and approved the final version of the manuscript.
Acknowledgement
This work was supported in part by the Providence Foundation Ltd, in
memory of the late Lui Hac Minh, Cheer Master Investments Ltd (Mr Yeung
Sai Hong), and a donation from Larry Chi-Kin Yung.
Author details
1Department of Microbiology, The University of Hong Kong, Hong Kong
Special Administrative Region, China. 2State Key Laboratory for Emerging
Infectious Diseases, The University of Hong Kong, Hong Kong Special
Administrative Region, China. 3Carol Yu Centre for Infection, The University of
Hong Kong, Hong Kong Special Administrative Region, China. 4Research
Centre of Infection and Immunology, The University of Hong Kong, Hong
Kong Special Administrative Region, China. 5Collaborative Innovation Center
for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Received: 7 January 2016 Accepted: 8 March 2016
References
1. To KK, Chan JF, Chen H, Li L, Yuen KY. The emergence of influenza A H7N9
in human beings 16 years after influenza A H5N1: a tale of two cities.
Lancet Infect Dis. 2013;13:809–21.
2. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q,
Cui D, et al. Human infections with the emerging avian influenza A
H7N9 virus from wet market poultry: clinical analysis and
characterisation of viral genome. Lancet. 2013;381:1916–25.
3. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al.
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl
J Med. 2013;368:1888–97.
4. To KK, Song W, Lau SY, Que TL, Lung DC, Hung IF, Chen H, Yuen KY. Unique
reassortant of influenza A(H7N9) virus associated with severe disease
emerging in Hong Kong. J Infect. 2014;69:60–8.
5. Marjuki H, Mishin VP, Chesnokov AP, Jones J, De La Cruz JA, Sleeman K,
Tamura D, Nguyen HT, Wu HS, Chang FY, et al. Characterization of drug-
resistant influenza A(H7N9) variants isolated from an oseltamivir-treated
patient in Taiwan. J Infect Dis. 2015;211:249–57.
6. William T, Thevarajah B, Lee SF, Suleiman M, Jeffree MS, Menon J, Saat Z,
Thayan R, Tambyah PA, Yeo TW et al. Avian influenza (H7N9) virus infection
in Chinese tourist in Malaysia, 2014. Emerg Infect Dis. 2015;21:142–5.
7. World Health Organization: Human infection with avian influenza A(H7N9)
virus – Canada. Available at http://www.who.int/csr/don/01-february-2015-
avian-influenza/en/. Accessed on December 10, 2015.
8. Centre for Health Protection: Avian Influenza Report. Reporting period:
December 6, 2015 – December 12, 2015 (Week 50). 2015.
9. World Health Organization: Influenza at the human-animal interface.
Summary and assessment as of 14 December 2015. Available at http://
www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_
HA_interface_14_Dec_2015.pdf?ua=1. Accessed on December 23, 2015.
10. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic
influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev.
2012;25:223–63.
11. To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, Chen H, Yuen K. Avian
influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect.
2012;1, e25.
12. To KK, Chan JF, Yuen KY. Viral lung infections: epidemiology, virology,
clinical features, and management of avian influenza A(H7N9). Curr Opin
Pulm Med. 2014;20:225–32.
To et al. Virology Journal  (2016) 13:42 Page 6 of 7
13. Wang C, Yu H, Horby PW, Cao B, Wu P, Yang S, Gao H, Li H, Tsang TK, Liao
Q, et al. Comparison of patients hospitalized with influenza A subtypes
H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis. 2014;58:1095–103.
14. Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced
acute respiratory distress syndrome. Lancet Infect Dis. 2014;14:57–69.
15. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, To KK, Chen H, Yang Y, Liang W
et al. Clinical, virological, and histopathological manifestations of fatal human
infections by avian influenza A(H7N9) virus. Clin Infect Dis. 2013;57:1449–57.
16. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt
CL, et al. Delayed clearance of viral load and marked cytokine activation in
severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect
Dis. 2010;50:850–9.
17. Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, Zou Z, Liu S, Pan J, Bao C, et
al. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-
Infected Patients can Predict Fatal Outcomes. Sci Rep. 2015;5:10942.
18. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, Ren Y, Wang J, Dong Y,
Bao M, et al. Early hypercytokinemia is associated with interferon-
induced transmembrane protein-3 dysfunction and predictive of fatal
H7N9 infection. Proc Natl Acad Sci U S A. 2014;111:769–74.
19. Guo L, Zhang X, Ren L, Yu X, Chen L, Zhou H, Gao X, Teng Z, Li J, Hu
J, et al. Human antibody responses to avian influenza A(H7N9) virus,
2013. Emerg Infect Dis. 2014;20:192–200.
20. Lee AC, Zhu H, Zhang AJ, Li C, Wang P, Li C, Chen H, Hung IF, To KK, Yuen
KY. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus
Is Related to Its Internal Genes. Clin Vaccine Immunol. 2015;22:1235–43.
21. Wu D, Zou S, Bai T, Li J, Zhao X, Yang L, Liu H, Li X, Yang X, Xin L, et al.
Poultry farms as a source of avian influenza A (H7N9) virus reassortment
and human infection. Sci Rep. 2015;5:7630.
22. Cui L, Liu D, Shi W, Pan J, Qi X, Li X, Guo X, Zhou M, Li W, Li J, et al.
Dynamic reassortments and genetic heterogeneity of the human-infecting
influenza A (H7N9) virus. Nat Commun. 2014;5:3142.
23. Yang S, Chen Y, Cui D, Yao H, Lou J, Huo Z, Xie G, Yu F, Zheng S, Yang Y et
al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected
areas of China: a serological study. J Infect Dis. 2014;209:265–9.
24. Li C, Li C, Zhang AJ, To KK, Lee AC, Zhu H, Wu HW, Chan JF, Chen H, Hung
IF, et al. Avian influenza A H7N9 virus induces severe pneumonia in mice
without prior adaptation and responds to a combination of zanamivir and
COX-2 inhibitor. PLoS ONE. 2014;9:e107966.
25. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles
induced by the novel swine-origin influenza A/H1N1 virus: implications for
treatment strategies. J Infect Dis. 2010;201:346–53.
26. Li IW, Chan KH, To KW, Wong SS, Ho PL, Lau SK, Woo PC, Tsoi HW, Chan JF,
Cheng VC, et al. Differential susceptibility of different cell lines to swine-
origin influenza A H1N1, seasonal human influenza A H1N1, and avian
influenza A H5N1 viruses. J Clin Virol. 2009;46:325–30.
27. Zhang AJ, To KK, Li C, Lau CC, Poon VK, Chan CC, Zheng BJ, Hung IF, Lam KS,
Xu A, Yuen KY. Leptin mediates the pathogenesis of severe 2009 pandemic
influenza A(H1N1) infection associated with cytokine dysregulation in mice
with diet-induced obesity. J Infect Dis. 2013;207:1270–80.
28. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen
H, Che XY, et al. Differential cell line susceptibility to the emerging novel
human betacoronavirus 2c EMC/2012: implications for disease pathogenesis
and clinical manifestation. J Infect Dis. 2013;207:1743–52.
29. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, NV,
Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1)
is associated with high viral load and hypercytokinemia. Nat Med. 2006;
12:1203–7.
30. Chan JF, To KK, Tse H, Lau CC, Li IW, Hung IF, Chan KH, Cheng VC, Lai TS,
Woo PC, et al. The lower serum immunoglobulin G2 level in severe cases
than in mild cases of pandemic H1N1 2009 influenza is associated with
cytokine dysregulation. Clin Vaccine Immunol. 2011;18:305–10.
31. Zeng H, Belser JA, Goldsmith CS, Gustin KM, Veguilla V, Katz JM,
Tumpey TM: A(H7N9) virus results in early induction of proinflammatory
cytokine responses in both human lung epithelial and endothelial cells
and shows increased human adaptation compared with avian H5N1
virus. J Virol. 2015;89:4655–67.
32. Chan MC, Chan RW, Chan LL, Mok CK, Hui KP, Fong JH, Tao KP, Poon LL,
Nicholls JM, Guan Y, Peiris JS: Tropism and innate host responses of a novel
avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of
the human respiratory tract. Lancet Respir Med. 2013;1:534–42.
33. Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, Pantin-
Jackwood MJ, Tumpey TM, Katze MG: H7N9 and other pathogenic avian
influenza viruses elicit a three-pronged transcriptomic signature that is
reminiscent of 1918 influenza virus and is associated with lethal outcome in
mice. J Virol. 2014;88:10556–68.
34. Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG. Transcriptomic
characterization of the novel avian-origin influenza A (H7N9) virus: specific
host response and responses intermediate between avian (H5N1 and H7N7)
and human (H3N2) viruses and implications for treatment options. MBio.
2014;5:e01102–13.
35. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, et al.
H7N9 influenza viruses are transmissible in ferrets by respiratory droplet.
Science. 2013;341:410–4.
36. Davis AS, Chertow DS, Moyer JE, Suzich J, Sandouk A, Dorward DW, Logun
C, Shelhamer JH, Taubenberger JK: Validation of normal human bronchial
epithelial cells as a model for influenza A infections in human distal trachea.
J Histochem Cytochem. 2015;63:312–28.
37. Pearce MB, Jayaraman A, Pappas C, Belser JA, Zeng H, Gustin KM, Maines TR,
Sun X, Raman R, Cox NJ, et al. Pathogenesis and transmission of swine
origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A. 2012;
109:3944–9.
38. Aevermann BD, Pickett BE, Kumar S, Klem EB, Agnihothram S, Askovich PS,
Bankhead A, 3rd, Bolles M, Carter V, Chang J, et al. A comprehensive
collection of systems biology data characterizing the host response to viral
infection. Sci Data. 2014;1:140033.
39. Lau SK, Lau CC, Chan KH, Li CP, Chen H, Jin DY, Chan JF, Woo PC, Yuen KY:
Delayed induction of proinflammatory cytokines and suppression of innate
antiviral response by the novel Middle East respiratory syndrome
coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013;
94:2679–90.
40. McDermott JE, Shankaran H, Eisfeld AJ, Belisle SE, Neuman G, Li C,
McWeeney S, Sabourin C, Kawaoka Y, Katze MG, Waters KM: Conserved host
response to highly pathogenic avian influenza virus infection in human cell
culture, mouse and macaque model systems. BMC Syst Biol. 2011;5:190.
41. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, Nicholls JM, Zhu H, Guan
Y, Peiris JM: Pathogenicity of the novel A/H7N9 influenza virus in mice.
MBio. 2013;4.
42. Chi Y, Zhu Y, Wen T, Cui L, Ge Y, Jiao Y, Wu T, Ge A, Ji H, Xu K, et al.
Cytokine and chemokine levels in patients infected with the novel avian
influenza A (H7N9) virus in China. J Infect Dis. 2013;208:1962–7.
43. Allen TC, Kurdowska A. Interleukin 8 and acute lung injury. Arch Pathol Lab
Med. 2014;138:266–9.
44. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL,
Mason RJ: Differentiated human alveolar type II cells secrete antiviral IL-
29 (IFN-lambda 1) in response to influenza A infection. J Immunol.
2009;182:1296–304.
45. Sutejo R, Yeo DS, Myaing MZ, Hui C, Xia J, Ko D, Cheung PC, Tan BH, Sugrue
RJ: Activation of type I and III interferon signalling pathways occurs in lung
epithelial cells infected with low pathogenic avian influenza viruses. PLoS
ONE. 2012;7:e33732.
46. Narasaraju T, Ng HH, Phoon MC, Chow VT. MCP-1 antibody treatment
enhances damage and impedes repair of the alveolar epithelium in
influenza pneumonitis. Am J Respir Cell Mol Biol. 2010;42:732–43.
47. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami
S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, et al. Characterization of
H7N9 influenza A viruses isolated from humans. Nature. 2013;501:551–5.
48. Knepper J, Schierhorn KL, Becher A, Budt M, Tonnies M, Bauer TT, Schneider
P, Neudecker J, Ruckert JC, Gruber AD, et al. The novel human influenza
A(H7N9) virus is naturally adapted to efficient growth in human lung tissue.
MBio. 2013;4:e00601–13.
49. Zhao C, Qi X, Ding M, Sun X, Zhou Z, Zhang S, Zen K, Li X: Proinflammatory
cytokine dysregulation is associated with novel avian influenza A (H7N9)
virus in primary human macrophages. J Gen Virol. 2015.
To et al. Virology Journal  (2016) 13:42 Page 7 of 7
